Register entryRepackager / relabeller

HLS Therapeutics (USA), Inc

Data as of · How to read this entry

Registered sites
1
Active NDC listings
2
Live patents
0
Countries
1
Base
United States
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
HLS Therapeutics (USA), Inc.Registrant: HLS Therapeutics (USA), Inc919 Conestoga Road, Building Three, Suite 310, Rosemont, Pennsylvania (PA) 19010, United States (USA)Labelling3013003512079808066
Catalogue

Drug listings by form and route

2

2 active NDC listings: 2 human prescription drug. By marketing category: NDA 2.

Dosage formNDCs
tablet2
RouteNDCs
oral2
Labeller name on the listingNDCs
hls therapeutics (usa), inc.2
Catalogue

Marketed products

2
BrandGeneric nameForm / routeNDC
Clozarilclozapinetablet, oral69809-0126NDA
Clozarilclozapinetablet, oral69809-0127NDA
Compare

Comparable companies in United States

Enquiry

Common questions

Is HLS Therapeutics (USA), Inc FDA approved?
HLS Therapeutics (USA), Inc holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are HLS Therapeutics (USA), Inc's registered sites?
The FDA register lists Rosemont, PA. Registered operations: labelling.
What drugs does HLS Therapeutics (USA), Inc make?
2 products are listed under HLS Therapeutics (USA), Inc in the openFDA NDC Directory, most often as tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.